Work

Feasibility of real-time serial comprehensive tumor analytics: Pilot study of olaparib and durvalumab in metastatic triple negative breast cancer (mTNBC).

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.e13092

Authors: Allen Li, Marilyne Labrie, Jacqueline Vuky, Jeong Youn Lim, Brett Johnson, Sam Sivagnanam, Courtney Betts, Lisa Coussens, Christopher L. Corless, Raymond C. Bergan, Joe W. Gray, Gordon B. Mills, Zahi Ibrahim Mitri

Institutions: Oregon Health & Science University, OHSU Knight Cancer Institute

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3030338735

Cites:

Cited by: 4

Related to: 10